Beyond Prognosis: How Studying Cancer Overachievers Can Redefine the Future of Oncology Innovation
Nicolas Wolikow, Co-Founder and CEO at Cure51, on Ethical Principles in TechBio Cancer care is traditionally designed around the typical…
The Role of Real-World Evidence in Accelerating Drug Development
Nicolas Wolikow, Co-Founder and CEO at Cure51, on Ethical Principles in TechBio In today’s tech-driven landscape, few sectors are transforming…
Cure51 – Ethical Principles in TechBio: Balancing Innovation with Responsibility
Nicolas Wolikow, Co-Founder and CEO at Cure51, on Ethical Principles in TechBio Nicolas Wolikow, Co-Founder and CEO at Cure51 The…
Finnish biotech Enifer secures €36M to solve the world’s soaring protein need
The Finnish biotech scaleup is gearing up the production of its PEKILO® mycoprotein with a new €33M factory located in Kirkkonummi, Finland….
Berlin biotech startup Cultimate Foods raises € 2.3M seed
Seed funding from leading Biotech and Foodtech investors to revolutionize the alternative meat industry. Cultimate Foods, a biotech startup based…
French Cure51 Secures €15M Seed Funding to Revolutionize Cancer Treatment with Survivor Research
Unveiling Cure51’s Revolutionary Approach in Cancer Treatment with Techbio Innovations Cure51, a forward-thinking techbio firm, has recently garnered a substantial…